Oslo, Norway, December 18, 2025 - The Board of Directors of Nykode Therapeutics
ASA (OSE: NYKD) hereby calls for an Extraordinary General Meeting (EGM) to be
held at meeting room VIA - Building G, Floor 0 in Gaustadalléen 21, Oslo, Norway
at 10:00 CET on January 21, 2026.
The purpose of the meeting is to elect a new Chair of the Board and additional
Board members, including the current interim Chair of the Board.
The notice of the EGM is attached. All documents regarding the EGM will also be
made available at the Company's website:
https://nykode.com/investors/shareholder-meetings/
For further information, please see the Company's website or contact the Company
at IR@nykode.com
This information is subject to the disclosure requirements pursuant to sections
5-12 of the Norwegian Securities Trading Act.